11/14/2024
6:38 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024
5:49 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
5:53 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
5:57 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2024
8:04 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024
4:03 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
7:41 AM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/11/2024
3:15 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:13 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:24 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024
3:17 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
4:14 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
5:18 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
7:12 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
3:52 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
4:12 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024
6:14 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
8:17 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
6:28 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:35 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
7:53 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/22/2024
3:31 PM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024
7:34 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024
5:56 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2024
5:32 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2024
5:34 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
8:08 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024
7:07 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024
6:18 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
6:46 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
3:36 PM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
6:18 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
5:48 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
4:05 PM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
6:12 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
6:57 AM | BioNTech (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/20/2024
6:33 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
6:11 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
8:04 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
7:41 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
5:26 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
02/14/2024
6:26 AM | BioNTech (Subject)
Medine GmbH (Filed by)
| Form SC 13G/A | |
02/08/2024
5:08 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2024
4:03 PM | ATHOS KG (Filed by)
BioNTech (Subject)
| Form SC 13G/A | |
01/31/2024
6:47 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2024
8:14 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024
6:01 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/04/2024
7:02 AM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
3:22 PM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/07/2023
7:17 PM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
